Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,143,573
-
Share change
-
+7,648
-
Total reported value
-
$3,583,197
-
Price per share
-
$1.14
-
Number of holders
-
25
-
Value change
-
-$33,093
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q2 2023
As of 30 Jun 2023,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,143,573 shares.
The largest 10 holders included
Newtyn Management, LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Duquesne Family Office LLC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and NORTHERN TRUST CORP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.